Studiul urmareste evaluarea eficacitatii, sigurantei si calitatii vietii ca urmare a administrarii de daprodustat comparativ cu placebo la pacientii nedializati cu anemie si insuficienta renala cronica.

Titlu Studiu

A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo

Cod protocol: 205270

Numar EudraCT:

Sponsor: GlaxoSmithKline

Medicament de investigatie clinica: Daprodustat

Medicament de investigatie clinica comparator: nu

Placebo: da

International/National: international

Faza: III

Centre România

Cluj-Napoca, Romania, 400139

Targu Mures, Romania, 540096